Search Results
Aug 17, 2026, 11:55 ET Taiwan Weeks 2026 für den 3. bis 13. November mit erweiterter internationaler Beteiligung geplant
internationalen Verbindungen weiter stärken und Taiwan mit einem breiteren Spektrum an Themen und Teilnehmenden präsentieren", sagte FSC-Vorsitzender Dr. Jin-lung Peng. „Angesichts der rasanten Entwicklung der globalen Märkte wird die Regierung weiterhin Maßnahmen zur Marktöffnung vorantreiben, um Taiwans
More news about: Taiwan Stock Exchange Corporation
Aug 17, 2026, 10:30 ET Cancer Diagnostics Market worth $44.92 billion by 2031 - Exclusive Report by MarketsandMarkets™
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121The increasing global burden of cancer, including breast, lung, colorectal, prostate, cervical, and hematologic cancers, is significantly expanding the adoption of cancer diagnostics. The rising prevalence of cancer
More news about: MarketsandMarkets
Aug 17, 2026, 10:07 ET Azra AI and 4DMedical Partner to Bring Enterprise-Wide Lung Health Intelligence to Health Systems
with 4DMedical's quantitative lung imaging analytics, giving physicians objective, measurable data to guide the next stage of care.Identify. Connect. Manage.The offering spans a broad set of lung health care pathways: COPD/emphysema, interstitial lung disease (ILD), pulmonary nodules,
More news about: Azra AI
Aug 17, 2026, 09:56 ET 科倫博泰宣佈2026年中期業績
TNBC。期內取得的臨床進展如下：治療2L+ HR+/HER2- BC已獲批上市治療1L TNBC及1L PD-L1陽性NSCLC的新增適應症申請已獲受理治療1L PD-L1陰性非鱗狀NSCLC的OptiTROP-Lung06中國註冊性試驗達到主要終點治療2L+ EC的TroFuse-005全球性3期試驗達到主要終點2項治療OC及UC的全球3期試驗於2026年上半年啟動已啟動聯合SKB118治療NSCLC的2期研究獲得國家藥監局授予1項突破性療法認定，用於1L
More news about: 科倫博泰
Aug 17, 2026, 08:04 ET First Ascent Biomedical Names Dr. Gilberto Lopes Chairman of Its Medical Advisory Board
investigator of KEYNOTE-042, a pivotal clinical trial that contributed to an FDA approval of pembrolizumab for certain patients with advanced non-small cell lung cancer.As Chairman of First Ascent's Medical Advisory Board, Dr. Lopes will help guide the company's scientific strategy and continued evidence-development
More news about: First Ascent Biomedical
Aug 17, 2026, 08:00 ET OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors
studies have demonstrated broad anti-tumor activity for ONC-783 across multiple solid tumor and hematologic malignancies, including pancreatic cancer, lung cancer, breast cancer, colorectal cancer, ovarian cancer, glioblastoma, and mantle cell lymphoma, which supports the potential of ONC-783 as a treatment
More news about: OncoC4
Aug 17, 2026, 07:18 ET Kelun-Biotech Announces 2026 Interim Results
dermatitis.Clinical development progresses efficiently, with a tiered expansion of the pipeline matrixFocusing on high-incidence tumors such as lung cancer and breast cancer, the Company has built a well-layered clinical pipeline with significant synergistic potential, covering drug modalities including
More news about: Kelun-biotech
Aug 17, 2026, 05:51 ET Taiwan Weeks 2026 set for Nov. 3-13 with expanded international participation
continue to strengthen international connections and showcase Taiwan, with a broader range of topics and participants," said FSC Chairman Dr. Jin-lung Peng. "As global markets evolve rapidly, the government will continue to advance market-opening measures to support Taiwan's financial and industrial
More news about: Taiwan Stock Exchange Corporation
Aug 17, 2026, 05:28 ET Taiwan Weeks 2026 set for Nov. 3-13 with expanded international participation
continue to strengthen international connections and showcase Taiwan, with a broader range of topics and participants," said FSC Chairman Dr. Jin-lung Peng. "As global markets evolve rapidly, the government will continue to advance market-opening measures to support Taiwan's financial and industrial
More news about: Taiwan Stock Exchange Corporation
Aug 17, 2026, 00:08 ET Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform
product, serplulimab (trade name: Hetronifly® in Europe), is the world's first anti–PD-1 mAb approved for first-line treatment of small cell lung cancer and for perioperative gastric cancer. Up to date, it has been approved in 50 markets worldwide with an accelerated globalisation
More news about: Henlius
Aug 14, 2026, 17:02 ET Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update
antigen distinct from PSMA and has demonstrated preclinical activity across metastatic castration-resistant prostate cancer (mCRPC), non-small cell lung cancer (NSCLC), and breast cancer. Actimab-A has shown improved survival in relapsed/refractory AML with CLAG-M and is advancing toward a Phase 2/3
More news about: Actinium Pharmaceuticals, Inc.
Aug 14, 2026, 11:16 ET BIOSAPIEN - THE REVOLUTIONARY CANCER PLATFORM DEVELOPER - NOMINATED AS "BEST STARTUP" IN THE 2026 PRIX GALIEN USA AWARDS
safety.BioSapien is initially developing its platform for clinical trials in colorectal cancer patients, with scope to branch out to other cancers (pancreatic, lung), and non-cancer indications. Colorectal cancer is the most common cancer in men, the third most common cancer in women after breast and thyroid cancer,
More news about: BioSapien Inc
Aug 14, 2026, 10:00 ET March of Dimes and Publix kick off annual in-store campaign to support healthy starts for moms and babies
were born preterm and required specialized care in the neonatal intensive care unit (NICU). "Seeing that one of our sons could be born with a collapsed lung and only need a chest tube for two days because of the research March of Dimes has funded over the years is a miracle," he said. "I'm proud to know
More news about: March of Dimes
Aug 14, 2026, 07:52 ET Fractal's Vaidya.ai Powers BMC Health AI Chatbot on WhatsApp for Mumbai
Qure.ai, a global healthcare AI leader focused on the rapid identification and management of tuberculosis, lung cancer, and stroke (or critical health conditions). Fractal's suite of businesses consists of Asper.ai (a
More news about: Fractal Analytics Limited
Aug 14, 2026, 06:34 ET ArkBio's RSV Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial
ArkBioArkBio is a commercial-stage biotechnology company focused on the discovery and development of innovative therapeutics for respiratory/lung and pediatric diseases. Founded in 2014, the company has established proprietary technology platforms and a differentiated R&D pipeline through
More news about: Shanghai Ark Biopharmaceutical Co., Ltd.
Aug 14, 2026, 06:08 ET ArkBio's RSV Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial
ArkBioArkBio is a commercial-stage biotechnology company focused on the discovery and development of innovative therapeutics for respiratory/lung and pediatric diseases. Founded in 2014, the company has established proprietary technology platforms and a differentiated R&D pipeline through
More news about: Shanghai Ark Biopharmaceutical Co., Ltd.
Aug 14, 2026, 03:00 ET Canon Medical Systems GmbH and Coreline Soft Bring Integrated CT-AI Screening Workflow to Lostau, Germany
operation of low-dose CT-based lung cancer screening in the Lostau region of Germany. The contract highlights a workflow-oriented approach in which CT imaging infrastructure, AI-based chest CT analysis, and screening workflow support are provided together as Germany advances lung cancer screening within its
More news about: Coreline Soft
Aug 13, 2026, 16:10 ET VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update
working with our long-term collaborators at the Hospices Civils de Lyon, one of Europe's leading cancer centers, on the reimbursement submission for Nu.Q® Lung Cancer. Reimbursement is the last step on the path to the first use of Nu.Q® in routine clinical practice, an exciting prospect which is core to Volition's
More news about: VolitionRx Limited
Aug 13, 2026, 10:31 ET Bronchiectasis Market is Expected to Surge at a CAGR of 15% by 2036, Owing to the Launch of DPP1/CatC Inhibitors, Therapeutic Phage Cocktails, Nebulized Mucoactive Agents, and Other Novel Mechanisms | DelveInsight
bronchodilators, to control symptoms associated with chronic airway inflammation, recurrent respiratory infections, and progressive structural lung damage. While these therapies can provide symptomatic relief by improving airflow and reducing symptoms such as wheezing and dyspnea, they
More news about: DelveInsight Business Research, LLP
Aug 13, 2026, 10:12 ET Olympus Announces Global Distribution Agreement with Endocision for Respiratory Cryobiopsy System
and enhance Olympus' respiratory portfolio, which includes endobronchial ultrasound (EBUS) that plays a key role in the visualization and biopsy of lung tissue and lymph nodes."This agreement with Endocision highlights Olympus' commitment to strengthening our respiratory solutions that range from
More news about: Olympus
Aug 13, 2026, 10:12 ET Olympus Announces Global Distribution Agreement with Endocision for Respiratory Cryobiopsy System
and enhance Olympus' respiratory portfolio, which includes endobronchial ultrasound (EBUS) that plays a key role in the visualization and biopsy of lung tissue and lymph nodes."This agreement with Endocision highlights Olympus' commitment to strengthening our respiratory solutions that range from
More news about: Olympus
Aug 13, 2026, 10:00 ET First Responders Children's Foundation Announces 2026 CSX Pride in Service Scholarship Recipients
Aviation with the goal of becoming a professional pilot. Luca's father is a retired FDNY Captain who is now on line-of-duty disability due to chronic lung disease after extensive exposure at the World Trade Center site following the September 11 attacks.Emily Bartz from Maryland: Emily
More news about: First Responders Children's Foundation
Aug 13, 2026, 09:10 ET IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation
cryoablation therapy systems for the destruction of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally invasive technology is a safe and effective option to surgical tumor removal that is easily performed in a relatively short procedure.
More news about: IceCure Medical
Aug 13, 2026, 09:00 ET Coreline Soft and Optellum announce intent to collaborate to advance AI across the lung cancer pathway
CT-based lung nodule detection and lung cancer screening workflow with Optellum's lung nodule risk assessment and management workflow," he added. "Together, we aim to contribute to a more connected, efficient, and scalable lung cancer care
More news about: Coreline Soft
Aug 13, 2026, 08:15 ET Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger
technology. The Company's proprietary product pipeline includes treatments for central nervous system ("CNS") disorders such as acute migraine and serious lung diseases such as Chronic Obstructive Pulmonary Disease ("COPD") and allergic bronchopulmonary aspergillosis ("ABPA"). Pulmatrix's product candidates
More news about: Pulmatrix Inc.